What is Veradermics 's payments of stock issuance costs?

Veradermics (MANE) reported payments of stock issuance costs of $111.75K in Q4 2025.

How has Veradermics 's payments of stock issuance costs changed year-over-year?

Veradermics 's payments of stock issuance costs increased by 58.0% year-over-year, from $70.75K to $111.75K.

Veradermics MANE Payments Of Stock Issuance Costs

Payments Of Stock Issuance Costs at other companies

Sun CommunitiesSUI

$0-100%

Applied DigitalAPLD

$72K-97.6%

Jaguar Uranium JAGU

$10.75K—

AECOMACM

$3.05M—

Lineage, Inc.LINE

$0-100%

Chicago Atlantic Real Estate FinanceREFI

——

Other financials

Income statement

See full

Operating income-$29.9M-131%

Net income-$27.2M-120%

EPS (diluted)-$1.32+93.3%

Balance sheet

See full

Cash & equivalents$168.4M+419%

Total debt$4.0K—

Total equity$390.6M+744%

Total assets$397.4M—

Cash flow

See full

Operating cash flow-$21.2M-59.0%

CapEx--100%

Free cash flow-$21.2M-58.7%

Valuation

See full

Market cap$3.92B—

Returns & leverage

See full

Return on equity-28.7%—

Current ratio59.1×—

Where this comes from

Reported directly by Veradermics in its filing.

Tagged under the XBRL concept us-gaap:PaymentsOfStockIssuanceCosts.

The official record: Veradermics ’s 10-K, filed March 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Veradermics 's payments of stock issuance costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Veradermics 's payments of stock issuance costs?: Veradermics (MANE) reported payments of stock issuance costs of $111.75K in Q4 2025.
How has Veradermics 's payments of stock issuance costs changed year-over-year?: Veradermics 's payments of stock issuance costs increased by 58.0% year-over-year, from $70.75K to $111.75K.